Global Market Report

Global Remicade Biosimilar Market Professional Research Report 2013-2025, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Nov 22, 2018
  • PAGES：142
  • REPORT CODE：GMM131108
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Remicade Biosimilar witnessed a growth from XX.00 Million USD in 2013 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2018-2025 Remicade Biosimilar market is offered. The research provides insights for the global Remicade Biosimilar market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Remicade Biosimilar industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Remicade Biosimilar Market Segmentations:

    By Players:

    • Celltrion

    • Hospira

    • LG Life Sciences

    • Genentech (Roche Group)

    • Novartis (Sandoz)

    • Teva Pharmaceutical Industries

    • Synthon Pharmaceuticals

    • Biogen idec Inc.

    • Biocon

    • Merck Serono (Merck Group)


    By Types:

    • 100mg/10ml

    • 500mg/50ml


    By End-User:

    • Blood Disorders

    • Oncology Diseases


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Remicade Biosimilar Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Remicade Biosimilar Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Remicade Biosimilar Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Remicade Biosimilar Market Share by Types

      • 1.3.2 Global Remicade Biosimilar Market Size and Growth Rate of 100mg/10ml from 2013 to 2025

      • 1.3.3 Global Remicade Biosimilar Market Size and Growth Rate of 500mg/50ml from 2013 to 2025

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Remicade Biosimilar Market Share by End-Users

      • 1.4.2 Global Remicade Biosimilar Market Size and Growth Rate of Blood Disorders from 2013 to 2025

      • 1.4.3 Global Remicade Biosimilar Market Size and Growth Rate of Oncology Diseases from 2013 to 2025

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.1 United States Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.2 Canada Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.1.3 Mexico Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.2 Europe Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.1 Germany Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.2 UK Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.3 France Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.4 Italy Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.5 Nordic Countries Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.6 Spain Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.7 BelgiumRemicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.8 Poland Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.9 Russia Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.2.10 Turkey Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.3 Asia-Pacific Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.1 China Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.2 Japan Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.3 Australia and New Zealand Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.4 India Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.5 ASEAN Countries Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.3.6 South Korea Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

      • 1.5.4 Latin America, Middle East & Africa Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.1 GCC Countries Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.2 Brazil Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.3 Nigeria Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.4 South Africa Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

        • 1.5.4.5 Argentina Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Remicade Biosimilar Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Remicade Biosimilar by Major Types

      • 3.4.1 Market Size and Growth Rate of 100mg/10ml

      • 3.4.2 Market Size and Growth Rate of 500mg/50ml


    4 Segmentation of Remicade Biosimilar Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Remicade Biosimilar by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Remicade Biosimilar for Blood Disorders

      • 4.4.2 Market Size and Growth Rate of Remicade Biosimilar for Oncology Diseases


    5 Market Analysis by Major Regions

    • 5.1 Global Remicade Biosimilar Production Analysis by Major Regions

    • 5.2 Global Remicade Biosimilar Consumption Analysis by Major Regions

    • 5.3 Global Remicade Biosimilar Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Remicade Biosimilar Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Remicade Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Remicade Biosimilar Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Remicade Biosimilar Production, Import, Consumption and Export Analysis


    6 Product Commodity of Remicade Biosimilar Market in Major Countries

    • 6.1 Top 5 Export Countries in Remicade Biosimilar market from 2013 to 2018

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Remicade Biosimilar market from 2013 to 2018

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Remicade Biosimilar market from 2013 to 2018

    • 6.2 Top 5 Import Countries in Remicade Biosimilar market from 2013 to 2018

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Remicade Biosimilar market from 2013 to 2018

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Remicade Biosimilar market from 2013 to 2018

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Remicade Biosimilar Landscape Analysis

    • 7.1 North America Remicade Biosimilar Landscape Analysis by Major Types

    • 7.2 North America Remicade Biosimilar Landscape Analysis by Major End-Users

    • 7.3 North America Remicade Biosimilar Landscape Analysis by Major Countries

      • 7.3.1 United States Remicade Biosimilar Market Volume and Growth Rate

      • 7.3.2 Canada Remicade Biosimilar Market Volume and Growth Rate

      • 7.3.3 Mexico Remicade Biosimilar Market Volume and Growth Rate


    8 Europe Remicade Biosimilar Landscape Analysis

    • 8.1 Europe Remicade Biosimilar Landscape Analysis by Major Types

    • 8.2 Europe Remicade Biosimilar Landscape Analysis by Major End-Users

    • 8.3 Europe Remicade Biosimilar Landscape Analysis by Major Countries

      • 8.3.1 Germany Remicade Biosimilar Market Volume and Growth Rate

      • 8.3.2 UK Remicade Biosimilar Market Volume and Growth Rate

      • 8.3.3 France Remicade Biosimilar Market Volume and Growth Rate

      • 8.3.4 Italy Remicade Biosimilar Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Remicade Biosimilar Market Volume and Growth Rate

      • 8.3.6 Spain Remicade Biosimilar Market Volume and Growth Rate

      • 8.3.7 Belgium Remicade Biosimilar Market Volume and Growth Rate

      • 8.3.8 Poland Remicade Biosimilar Market Volume and Growth Rate

      • 8.3.9 Russia Remicade Biosimilar Market Volume and Growth Rate

      • 8.3.10 Turkey Remicade Biosimilar Market Volume and Growth Rate


    9 Asia Pacific Remicade Biosimilar Landscape Analysis

    • 9.1 Asia Pacific Remicade Biosimilar Landscape Analysis by Major Types

    • 9.2 Asia Pacific Remicade Biosimilar Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Remicade Biosimilar Landscape Analysis by Major Countries

      • 9.3.1 China Remicade Biosimilar Market Volume and Growth Rate

      • 9.3.2 Japan Remicade Biosimilar Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Remicade Biosimilar Market Volume and Growth Rate

      • 9.3.4 India Remicade Biosimilar Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Remicade Biosimilar Market Volume and Growth Rate

      • 9.3.6 South Korea Remicade Biosimilar Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Remicade Biosimilar Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Remicade Biosimilar Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Remicade Biosimilar Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Remicade Biosimilar Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Remicade Biosimilar Market Volume and Growth Rate

      • 10.3.2 Brazil Remicade Biosimilar Market Volume and Growth Rate

      • 10.3.3 Nigeria Remicade Biosimilar Market Volume and Growth Rate

      • 10.3.4 South Africa Remicade Biosimilar Market Volume and Growth Rate 

      • 10.3.5 Argentina Remicade Biosimilar Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Celltrion

      • 11.1.1 Celltrion Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Hospira

      • 11.2.1 Hospira Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 LG Life Sciences

      • 11.3.1 LG Life Sciences Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Genentech (Roche Group)

      • 11.4.1 Genentech (Roche Group) Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Novartis (Sandoz)

      • 11.5.1 Novartis (Sandoz) Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Teva Pharmaceutical Industries

      • 11.6.1 Teva Pharmaceutical Industries Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Synthon Pharmaceuticals

      • 11.7.1 Synthon Pharmaceuticals Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Biogen idec Inc.

      • 11.8.1 Biogen idec Inc. Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Biocon

      • 11.9.1 Biocon Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Merck Serono (Merck Group)

      • 11.10.1 Merck Serono (Merck Group) Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 88 Figures and 136 Tables)

    • Figure Product Picture

    • Figure Global Remicade Biosimilar Market Size and Growth Rate of 100mg/10ml from 2013 to 2025

    • Figure Global Remicade Biosimilar Market Size and Growth Rate of 500mg/50ml from 2013 to 2025

    • Figure Market Share by Type in 2013

    • Figure Market Share by Type in 2017

    • Figure Market Share by Type in 2025

    • Figure Global Remicade Biosimilar Market Size and Growth Rate of Blood Disorders from 2013 to 2025

    • Figure Global Remicade Biosimilar Market Size and Growth Rate of Oncology Diseases from 2013 to 2025

    • Figure Market Share by End-User in 2013

    • Figure Market Share by End-User in 2017

    • Figure Market Share by End-User in 2025

    • Figure North America Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure United States Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Canada Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Mexico Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Europe Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Germany Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure UK Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure France Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Italy Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Spain Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Belgium Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Poland Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Russia Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Turkey Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Asia-Pacific Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure China Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Japan Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Australia and New Zealand Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure India Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Korea Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Latin America, Middle East & Africa Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure GCC Countries Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Brazil Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Nigeria Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure South Africa Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Argentina Remicade Biosimilar Consumption Market Size and Growth Rate from 2013 to 2025

    • Figure Development Trends and Industry Dynamics of Remicade Biosimilar Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2017

    • Figure Market Share of TOP 5 Players in 2017

    • Figure Market Share of TOP 6 Players from 2013 to 2018

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Remicade Biosimilar

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Remicade Biosimilar by Different Types from 2013 to 2025

    • Table Consumption Share of Remicade Biosimilar by Different Types from 2013 to 2025

    • Figure Market Size and Growth Rate of 100mg/10ml

    • Figure Market Size and Growth Rate of 500mg/50ml

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Remicade Biosimilar by Different End-Users from 2013 to 2025

    • Table Consumption Share of Remicade Biosimilar by Different End-Users from 2013 to 2025

    • Figure Market Size and Growth Rate of Blood Disorders

    • Figure Market Size and Growth Rate of Oncology Diseases

    • Table Global Remicade Biosimilar Production by Major Regions

    • Table Global Remicade Biosimilar Production Share by Major Regions

    • Figure Global Remicade Biosimilar Production Share by Major Regions in 2013

    • Figure Global Remicade Biosimilar Production Share by Major Regions in 2018

    • Figure Global Remicade Biosimilar Production Share by Major Regions in 2025

    • Table Global Remicade Biosimilar Consumption by Major Regions

    • Table Global Remicade Biosimilar Consumption Share by Major Regions

    • Figure Global Remicade Biosimilar Consumption Share by Major Regions in 2013

    • Figure Global Remicade Biosimilar Consumption Share by Major Regions in 2018

    • Figure Global Remicade Biosimilar Consumption Share by Major Regions in 2025

    • Table North America Remicade Biosimilar Production, Import, Consumption and Export Analysis

    • Table Europe Remicade Biosimilar Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Remicade Biosimilar Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Remicade Biosimilar Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Remicade Biosimilar market from 2013 to 2018

    • Table Top 5 Export Countries' Export Volume Analysis in Remicade Biosimilar market from 2013 to 2018

    • Table Top 5 Import Countries' Import Value Analysis in Remicade Biosimilar market from 2013 to 2018

    • Table Top 5 Import Countries' Import Volume Analysis in Remicade Biosimilar market from 2013 to 2018

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Remicade Biosimilar Consumption by Types from 2013 to 2025

    • Table North America Remicade Biosimilar Consumption Share by Types from 2013 to 2025

    • Figure North America Remicade Biosimilar Consumption Share by Types in 2013

    • Figure North America Remicade Biosimilar Consumption Share by Types in 2018

    • Figure North America Remicade Biosimilar Consumption Share by Types in 2025

    • Table North America Remicade Biosimilar Consumption by End-Users from 2013 to 2025

    • Table North America Remicade Biosimilar Consumption Share by End-Users from 2013 to 2025

    • Figure North America Remicade Biosimilar Consumption Share by End-Users in 2013

    • Figure North America Remicade Biosimilar Consumption Share by End-Users in 2018

    • Figure North America Remicade Biosimilar Consumption Share by End-Users in 2025

    • Table North America Remicade Biosimilar Consumption by Major Countries from 2013 to 2025

    • Table North America Remicade Biosimilar Consumption Share by Major Countries from 2013 to 2025

    • Figure North America Remicade Biosimilar Consumption Share by Major Countries in 2013

    • Figure North America Remicade Biosimilar Consumption Share by Major Countries in 2018

    • Figure North America Remicade Biosimilar Consumption Share by Major Countries in 2025

    • Figure United States Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Canada Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Mexico Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Table Europe Remicade Biosimilar Consumption by Types from 2013 to 2025

    • Table Europe Remicade Biosimilar Consumption Share by Types from 2013 to 2025

    • Figure Europe Remicade Biosimilar Consumption Share by Types in 2013

    • Figure Europe Remicade Biosimilar Consumption Share by Types in 2018

    • Figure Europe Remicade Biosimilar Consumption Share by Types in 2025

    • Table Europe Remicade Biosimilar Consumption by End-Users from 2013 to 2025

    • Table Europe Remicade Biosimilar Consumption Share by End-Users from 2013 to 2025

    • Figure Europe Remicade Biosimilar Consumption Share by End-Users in 2013

    • Figure Europe Remicade Biosimilar Consumption Share by End-Users in 2018

    • Figure Europe Remicade Biosimilar Consumption Share by End-Users in 2025

    • Table Europe Remicade Biosimilar Consumption by Major Countries from 2013 to 2025

    • Table Europe Remicade Biosimilar Consumption Share by Major Countries from 2013 to 2025

    • Figure Europe Remicade Biosimilar Consumption Share by Major Countries in 2013

    • Figure Europe Remicade Biosimilar Consumption Share by Major Countries in 2018

    • Figure Europe Remicade Biosimilar Consumption Share by Major Countries in 2025

    • Figure Germany Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure UK Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure France Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Italy Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Nordic Countries Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Belgium Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Poland Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Russia Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Turkey Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Table Asia Pacific Remicade Biosimilar Consumption by Types from 2013 to 2025

    • Table Asia Pacific Remicade Biosimilar Consumption Share by Types from 2013 to 2025

    • Figure Asia Pacific Remicade Biosimilar Consumption Share by Types in 2013

    • Figure Asia Pacific Remicade Biosimilar Consumption Share by Types in 2018

    • Figure Asia Pacific Remicade Biosimilar Consumption Share by Types in 2025

    • Table Asia Pacific Remicade Biosimilar Consumption by End-Users from 2013 to 2025

    • Table Asia Pacific Remicade Biosimilar Consumption Share by End-Users from 2013 to 2025

    • Figure Asia Pacific Remicade Biosimilar Consumption Share by End-Users in 2013

    • Figure Asia Pacific Remicade Biosimilar Consumption Share by End-Users in 2018

    • Figure Asia Pacific Remicade Biosimilar Consumption Share by End-Users in 2025

    • Table Asia Pacific Remicade Biosimilar Consumption by Major Countries from 2013 to 2025

    • Table Asia Pacific Remicade Biosimilar Consumption Share by Major Countries from 2013 to 2025

    • Figure Asia Pacific Remicade Biosimilar Consumption Share by Major Countries in 2013

    • Figure Asia Pacific Remicade Biosimilar Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Remicade Biosimilar Consumption Share by Major Countries in 2025

    • Figure China Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Japan Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Australia and New ZealandRemicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure India Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure ASEAN Countries Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure South Korea Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Table Latin America, Middle East & Africa Remicade Biosimilar Consumption by Types from 2013 to 2025

    • Table Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by Types from 2013 to 2025

    • Figure Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by Types in 2013

    • Figure Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by Types in 2025

    • Table Latin America, Middle East & Africa Remicade Biosimilar Consumption by End-Users from 2013 to 2025

    • Table Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by End-Users from 2013 to 2025

    • Figure Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by End-Users in 2013

    • Figure Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by End-Users in 2025

    • Table Latin America, Middle East & Africa Remicade Biosimilar Consumption by Major Countries from 2013 to 2025

    • Table Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by Major Countries from 2013 to 2025

    • Figure Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by Major Countries in 2013

    • Figure Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Remicade Biosimilar Consumption Share by Major Countries in 2025

    • Figure GCC Countries Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Brazil Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Nigeria Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure South Africa Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Figure Argentina Remicade Biosimilar Market Volume and Growth Rate from 2013 to 2025

    • Table Company Profile and Development Status of Celltrion

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion

    • Figure Sales and Growth Rate Analysis of Celltrion

    • Figure Revenue and Market Share Analysis of Celltrion

    • Table Product and Service Introduction of Celltrion

    • Table Company Profile and Development Status of Hospira

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira

    • Figure Sales and Growth Rate Analysis of Hospira

    • Figure Revenue and Market Share Analysis of Hospira

    • Table Product and Service Introduction of Hospira

    • Table Company Profile and Development Status of LG Life Sciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LG Life Sciences

    • Figure Sales and Growth Rate Analysis of LG Life Sciences

    • Figure Revenue and Market Share Analysis of LG Life Sciences

    • Table Product and Service Introduction of LG Life Sciences

    • Table Company Profile and Development Status of Genentech (Roche Group)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech (Roche Group)

    • Figure Sales and Growth Rate Analysis of Genentech (Roche Group)

    • Figure Revenue and Market Share Analysis of Genentech (Roche Group)

    • Table Product and Service Introduction of Genentech (Roche Group)

    • Table Company Profile and Development Status of Novartis (Sandoz)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis (Sandoz)

    • Figure Sales and Growth Rate Analysis of Novartis (Sandoz)

    • Figure Revenue and Market Share Analysis of Novartis (Sandoz)

    • Table Product and Service Introduction of Novartis (Sandoz)

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries

    • Table Product and Service Introduction of Teva Pharmaceutical Industries

    • Table Company Profile and Development Status of Synthon Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthon Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Synthon Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Synthon Pharmaceuticals

    • Table Product and Service Introduction of Synthon Pharmaceuticals

    • Table Company Profile and Development Status of Biogen idec Inc.

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biogen idec Inc.

    • Figure Sales and Growth Rate Analysis of Biogen idec Inc.

    • Figure Revenue and Market Share Analysis of Biogen idec Inc.

    • Table Product and Service Introduction of Biogen idec Inc.

    • Table Company Profile and Development Status of Biocon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon

    • Figure Sales and Growth Rate Analysis of Biocon

    • Figure Revenue and Market Share Analysis of Biocon

    • Table Product and Service Introduction of Biocon

    • Table Company Profile and Development Status of Merck Serono (Merck Group)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck Serono (Merck Group)

    • Figure Sales and Growth Rate Analysis of Merck Serono (Merck Group)

    • Figure Revenue and Market Share Analysis of Merck Serono (Merck Group)

    • Table Product and Service Introduction of Merck Serono (Merck Group)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US